Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds

Seminars in Cancer Biology
A R M Ruhul AminDong M Shin

Abstract

The evasion of anti-growth signaling is an important characteristic of cancer cells. In order to continue to proliferate, cancer cells must somehow uncouple themselves from the many signals that exist to slow down cell growth. Here, we define the anti-growth signaling process, and review several important pathways involved in growth signaling: p53, phosphatase and tensin homolog (PTEN), retinoblastoma protein (Rb), Hippo, growth differentiation factor 15 (GDF15), AT-rich interactive domain 1A (ARID1A), Notch, insulin-like growth factor (IGF), and Krüppel-like factor 5 (KLF5) pathways. Aberrations in these processes in cancer cells involve mutations and thus the suppression of genes that prevent growth, as well as mutation and activation of genes involved in driving cell growth. Using these pathways as examples, we prioritize molecular targets that might be leveraged to promote anti-growth signaling in cancer cells. Interestingly, naturally occurring phytochemicals found in human diets (either singly or as mixtures) may promote anti-growth signaling, and do so without the potentially adverse effects associated with synthetic chemicals. We review examples of naturally occurring phytochemicals that may be applied to prevent cancer...Continue Reading

References

Jan 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·P A Dennis, D B Rifkin
Jul 5, 1990·European Journal of Biochemistry·R E Humbel
Dec 1, 1988·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·D FernandezP G Fernandez
Aug 1, 1988·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F FischbachH Graeff
Apr 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·A G Knudson
Jan 1, 1994·Cold Spring Harbor Symposia on Quantitative Biology·K M DameronN Bouck
Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·T FotsisL Schweigerer
Jul 7, 1999·Journal of the National Cancer Institute·A TannapfelC Wittekind
Sep 17, 1999·The American Journal of Pathology·S KnuutilaY Zhu
Nov 24, 1999·The Journal of Experimental Medicine·J D HudsonD H Beach
Dec 22, 1999·Endocrine Reviews·V HwaR G Rosenfeld
Apr 6, 2000·The Journal of Biological Chemistry·S KahlertC Grohe
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·S WenD L Durden
Oct 31, 2001·Trends in Cell Biology·R J Akhurst, R Derynck
Feb 13, 2002·The American Journal of Pathology·Sétha Douc-RasyJean Bénard
Feb 20, 2002·FEBS Letters·Tathagata ChoudhuriGaurisankar Sa
Mar 30, 2002·The Journal of Biological Chemistry·Yoko OgawaraYukiko Gotoh
Aug 3, 2002·Nature Reviews. Cancer·Karen H Vousden, Xin Lu
Sep 18, 2002·Journal of Cell Science·Dwayne G Stupack, David A Cheresh
Nov 15, 2002·The New England Journal of Medicine·William C Hahn, Robert A Weinberg
Dec 3, 2002·Nature Reviews. Cancer·Marie Classon, Ed Harlow
Dec 6, 2002·Endocrine Reviews·Sue M Firth, Robert C Baxter
Mar 8, 2003·Proceedings of the National Academy of Sciences of the United States of America·John B WelshGarret M Hampton
Mar 22, 2003·Current Opinion in Cell Biology·Christopher L Brooks, Wei Gu
May 27, 2003·International Journal of Cancer. Journal International Du Cancer·Leigh C WilsonThomas E Eling
May 28, 2003·Cancer Letters·Derek LeRoith, Charles T Roberts
Jul 5, 2003·The Journal of Clinical Endocrinology and Metabolism·Lawrence A WetterauPinchas Cohen

❮ Previous
Next ❯

Citations

Oct 10, 2015·Biochemical and Biophysical Research Communications·Mamatha Garige, Eric Walters
Mar 27, 2019·Future Medicinal Chemistry·Christian Espinosa-BustosCristian O Salas
Mar 29, 2019·International Journal of Molecular Sciences·Cristina PorcheriThimios Mitsiadis
Dec 18, 2018·International Journal of Cancer. Journal International Du Cancer·Judith M GraberIris G Udasin
Jul 31, 2019·Phytotherapy Research : PTR·Moumita KunduMahitosh Mandal
Jul 3, 2019·BMC Complementary and Alternative Medicine·Luis Varela-RodríguezPatricia Talamás-Rohana
Mar 24, 2020·Nature Reviews. Clinical Oncology·Benedito A Carneiro, Wafik S El-Deiry
Jan 19, 2017·Oncotarget·Zhixiang ZhaoDong M Shin
Jan 4, 2019·BMC Research Notes·Bayan Al-DabbaghAmr Amin
Oct 23, 2019·BMC Complementary and Alternative Medicine·Jinsha KorothBibha Choudhary
May 28, 2020·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Danielle Barbosa BrottoWilson Araújo da Silva
Jul 4, 2020·Signal Transduction and Targeted Therapy·Zhe ZhangCanhua Huang
Jun 7, 2019·Cell Biochemistry and Function·Ghorban Ali TarfieiMohammad Hossein Ghahremani
Aug 17, 2019·Cells·Eliot Osher, Valentine M Macaulay
Aug 22, 2017·NPJ Precision Oncology·Jack L ArbiserLinda C Gilbert
Feb 7, 2020·Signal Transduction and Targeted Therapy·Sabina LuszczakSusan Heavey
Jun 20, 2020·BMC Complementary Medicine and Therapies·Bakht NasirIhsan-Ul Haq
Dec 9, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jelili A BadmusDonavon C Hiss
Apr 17, 2020·Signal Transduction and Targeted Therapy·Sabina LuszczakSusan Heavey
Apr 16, 2021·Cancer Management and Research·Tao GuoLin Zhang
May 10, 2017·Biochimica Et Biophysica Acta. General Subjects·Sakineh Kazemi NoureiniShozeb Haider
Oct 8, 2020·Molecular Therapy Oncolytics·Rui HanYong Zhu
Sep 15, 2018·Molecular Pharmaceutics·Yuanliang YanZhijie Xu
Mar 19, 2016·Chemical Research in Toxicology·Wenji LiAh-Ng Kong
Mar 20, 2018·Translational Research : the Journal of Laboratory and Clinical Medicine·Meera PatelJoanne Edwards

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

B cells: Gene Expression

B lymphocytes are white blood cells that play a role in the adaptive immune system by secreting antibodies. Here is the latest research on gene expression in B cells.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Cell Cycle Control & Proteolysis

Key regulators of cell cycle, including cyclins, cyclin dependent kinase inhibitors, DNA replication factors, are controlled by proteolysis. Discover the latest research on cell cycle control and proteolysis.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Related Papers

Seminars in Cancer Biology
Katerina PolitiJan Kitajewski
Shanghai kou qiang yi xue = Shanghai journal of stomatology
Jing-dong LiYan-li Xu
Nihon rinsho. Japanese journal of clinical medicine
Yumiko OishiRyozo Nagai
© 2022 Meta ULC. All rights reserved